Paper Details

  1. Home
  2. Paper Details

Surgical cytoreduction for recurrent epithelial ovarian cancer.

Author: Al RawahiThuria, BristowRobert E, BryantAndrew, ChattopadhyaySupratik, ElattarAhmed, GalaalKhadra, LopesAlberto D

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

The usual treatment for ovarian cancer is surgery followed by chemotherapy. While many women achieve remission, about 60% of those with advanced disease will experience a return of the cancer. There is no standard treatment for recurrent ovarian cancer, but surgery may be associated with a longer lifespan.
Paper Details　
Original Abstract of the Article :
The standard management of primary ovarian cancer is optimal cytoreductive surgery followed by platinum-based chemotherapy. Most women with primary ovarian cancer achieve remission on this combination therapy. For women achieving clinical remission after completion of initial treatment, most (60%) w...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457850/

データ提供：米国国立医学図書館（NLM）

Surgical Cytoreduction for Recurrent Ovarian Cancer

This research delves into the complex world of ovarian cancer, where recurrence is a significant concern. The study examines the role of surgical cytoreduction, a procedure that aims to remove as much cancer tissue as possible, in managing recurrent ovarian cancer. The authors highlight the current lack of a universally accepted standard treatment for this challenging condition. While surgery for recurrent ovarian cancer has been linked to improved survival, further research is needed to definitively establish its role and optimize treatment strategies. The authors emphasize the need for tailored approaches that consider individual patient factors and the specific characteristics of the recurrent cancer.

The Need for Effective Treatment Options

The study's findings underscore the pressing need for improved treatment options for women with recurrent ovarian cancer. While surgery can play a role, it is not a one-size-fits-all solution. Further research is needed to develop more effective therapies, including combinations of surgery, chemotherapy, and other targeted treatments. The researchers emphasize the importance of collaborative efforts between oncologists, surgeons, and other healthcare professionals to ensure that patients receive the best possible care.

Health Implications and Lifestyle Considerations

The research underscores the importance of early detection and comprehensive treatment for ovarian cancer. It also highlights the need for ongoing research to develop more effective and targeted therapies for recurrent disease. Women with a history of ovarian cancer should maintain regular checkups and work closely with their healthcare provider to monitor their health and manage any recurrence effectively. This is a challenging journey, but advancements in research and personalized medicine offer hope for improved outcomes.

Dr. Camel's Conclusion

The journey with ovarian cancer can feel like traversing a vast and shifting desert, full of uncertainty. This research emphasizes the importance of exploring all treatment options and collaborating with a healthcare team to navigate this terrain. While the path may be long and winding, research continues to offer new hope and potential for improved outcomes.
Date :
  1. Date Completed 2013-03-28
  2. Date Revised 2023-09-12
Further Info :

Pubmed ID

23450588

DOI: Digital Object Identifier

PMC6457850

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.